... Thrombocytopenia Platelet refractoriness Multitransfusion is a well-documented risk factor for the development of refractoriness to platelet transfusions [ 1 ]. Refractoriness to platelet transfusions has been reported to occur in 15-25% of hemato-oncological patients [ 1,2,3,4,5,6 ]. Poor response...

... is a significant complication of transfusions rendering platelet concentrates ineffective by blocking aggregation and leading to rapid removal of platelets from the circulation in GT [ 14 ]. Platelet refractoriness was the main reason for the uncontrollable intra-abdominal haemorrhage in our patient. We confirmed...